{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:07:29Z","timestamp":1789139249313,"version":"build-2803163510"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum fur Infektionsforschung eV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1328"],"award-info":[{"award-number":["SFB1328"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB841"],"award-info":[{"award-number":["SFB841"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jhepr.2021.100294","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T05:19:32Z","timestamp":1619155172000},"page":"100294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Human hepatitis D virus-specific T cell epitopes"],"prefix":"10.1016","volume":"3","author":[{"given":"Matin","family":"Kohsar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Landahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Neumann-Haefelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2021.100294_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jhep.2020.05.019","article-title":"Revisiting the estimation of hepatitis D global prevalence","volume":"73","author":"Miao","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/gutjnl-2018-317874","article-title":"Hepatitis D prevalence: problems with extrapolation to global population estimates","volume":"69","author":"Stockdale","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"issue":"9785","key":"10.1016\/j.jhepr.2021.100294_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2019.12.028","article-title":"Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1","volume":"72","author":"Spaan","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100294_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta","author":"Roulot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100294_bib9","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","author":"Alfaiate","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12876-020-1168-9","article-title":"High rates of cirrhosis and severe clinical events in patients with HBV\/HDV co-infection: longitudinal analysis of a German cohort","volume":"20","author":"Bockmann","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2021.100294_bib11","series-title":"Global hepatitis report 2017","year":"2017"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100294_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/v12111334","article-title":"Interplay between hepatitis D virus and the interferon response","volume":"12","author":"Zhang","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2021.100294_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coviro.2018.10.003","article-title":"HDV evolution-will viral resistance be an issue in HDV infection?","volume":"32","author":"Tabernero","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib14","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/s41467-019-10117-z","article-title":"Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in\u00a0vivo","volume":"10","author":"Perez-Vargas","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.31453","article-title":"Preliminary evidence for hepatitis delta virus exposure in patients who are apparently not infected with hepatitis B virus","volume":"73","author":"Chemin","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100294_bib16","article-title":"Hepatitis delta virus propagation enabled by hepatitis C virus-Scientifically intriguing, but is it relevant to clinical practice?","author":"Pfluger","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100294_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2015.08.009","article-title":"Hepatitis delta virus: from biological and medical aspects to current and investigational therapeutic options","volume":"122","author":"Alfaiate","year":"2015","journal-title":"Antivir Res"},{"issue":"1 Suppl","key":"10.1016\/j.jhepr.2021.100294_bib18","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","article-title":"The hepatitis delta virus: replication and pathogenesis","volume":"64","author":"Sureau","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib19","first-page":"419","article-title":"Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication","volume":"11","author":"Abeywickrama-Samarakoon","year":"2020","journal-title":"Nat\u00a0Commun"},{"issue":"16","key":"10.1016\/j.jhepr.2021.100294_bib20","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1128\/JVI.74.16.7204-7210.2000","article-title":"Origin of hepatitis delta virus mRNA","volume":"74","author":"Gudima","year":"2000","journal-title":"J\u00a0Virol"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100294_bib21","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/jvi.64.7.3192-3198.1990","article-title":"Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen","volume":"64","author":"Hsieh","year":"1990","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/v2010189","article-title":"Interaction of host cellular proteins with components of the hepatitis delta virus","volume":"2","author":"Greco-Stewart","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2021.100294_bib23","series-title":"Fields virology","first-page":"2222","article-title":"Hepatitis D virus","author":"Taylor","year":"2013"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100294_bib24","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1462-5822.2008.01231.x","article-title":"Viroids","volume":"10","author":"Tsagris","year":"2008","journal-title":"Cell Microbiol"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100294_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021568","article-title":"Hepatitis D virus replication","volume":"5","author":"Taylor","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12985-017-0845-y","article-title":"Hepatitis delta: virological and clinical aspects","volume":"14","author":"Botelho-Souza","year":"2017","journal-title":"Virol J"},{"issue":"6573","key":"10.1016\/j.jhepr.2021.100294_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/380454a0","article-title":"RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase","volume":"380","author":"Polson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2021.100294_bib28","first-page":"123","article-title":"Control of ADAR1 editing of hepatitis delta virus RNAs","volume":"353","author":"Casey","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.jhepr.2021.100294_bib29","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1128\/jvi.64.10.5066-5069.1990","article-title":"Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication","volume":"64","author":"Chao","year":"1990","journal-title":"J\u00a0Virol"},{"issue":"13","key":"10.1016\/j.jhepr.2021.100294_bib30","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1128\/JVI.79.13.7951-7958.2005","article-title":"RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus","volume":"79","author":"Lai","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/viro.1994.1109","article-title":"Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly","volume":"199","author":"Lee","year":"1994","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib32","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1128\/jvi.68.5.2958-2964.1994","article-title":"Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen","volume":"68","author":"Hwang","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2007.07.034","article-title":"Characterization of the nuclear localization signal of the hepatitis delta virus antigen","volume":"370","author":"Alves","year":"2008","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100294_bib34","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1074\/jbc.M004477200","article-title":"A\u00a0novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly","volume":"276","author":"Lee","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.jhepr.2021.100294_bib35","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/jvi.66.11.6641-6648.1992","article-title":"Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen","volume":"66","author":"Xia","year":"1992","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib36","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.29574","article-title":"Genetic diversity and worldwide distribution of the deltavirus genus: a study of 2,152 clinical strains","volume":"66","author":"Le Gal","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhepr.2021.100294_bib37","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jvh.13086","article-title":"Genetic diversity of hepatitis D virus genotype-1 in Europe allows classification into subtypes","volume":"26","author":"Karimzadeh","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0092-8674(00)81191-5","article-title":"Transcriptional fidelity and proofreading by RNA polymerase II","volume":"93","author":"Thomas","year":"1998","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.jhepr.2021.100294_bib39","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1128\/JVI.79.21.13310-13316.2005","article-title":"Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture","volume":"79","author":"Chang","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158557","article-title":"Evidence of an exponential decay pattern of the hepatitis delta virus evolution rate and fluctuations in quasispecies complexity in long-term studies of chronic delta infection","volume":"11","author":"Homs","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(92)90756-F","article-title":"Evolution of hepatitis delta virus RNA during chronic infection","volume":"188","author":"Lee","year":"1992","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF00173151","article-title":"Substitution rates in hepatitis delta virus","volume":"41","author":"Krushkal","year":"1995","journal-title":"J\u00a0Mol Evol"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib43","doi-asserted-by":"crossref","first-page":"510 e11","DOI":"10.1016\/j.cmi.2014.12.008","article-title":"Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study\u00a0and evolutionary pattern during disease progression","volume":"21","author":"Shirvani-Dastgerdi","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2018.02.021","article-title":"Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta\/lambda responses in hepatocytes","volume":"69","author":"Zhang","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2004.06.025","article-title":"Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection","volume":"41","author":"Hartwig","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2893.2005.00663.x","article-title":"The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells","volume":"13","author":"Hartwig","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2021.100294_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13366","article-title":"Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta","author":"Wranke","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(18)30663-7","article-title":"Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial","volume":"19","author":"Wedemeyer","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100294_bib51","article-title":"Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: results from the HIDIT-II study","author":"Bremer","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2021.100294_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coviro.2016.10.002","article-title":"Antiviral therapy of hepatitis delta virus infection - progress and challenges towards cure","volume":"20","author":"Wranke","year":"2016","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cld.2019.04.005","article-title":"HBV\/HDV coinfection: a challenge for therapeutics","volume":"23","author":"Koh","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100294_bib55","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0168-8278(18)30224-1","article-title":"GS-005 - final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV\/HDV co-infection","volume":"68","author":"Wedemeyer","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100294_bib56","series-title":"An overview of Hepcludex and why it is authorised in the EU","first-page":"1","article-title":"Hepcludex (bulevirtide)","year":"2020"},{"issue":"15","key":"10.1016\/j.jhepr.2021.100294_bib57","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s40265-020-01400-1","article-title":"Bulevirtide: first approval","volume":"80","author":"Kang","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jhepr.2021.100294_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.02.031","article-title":"Treatment of hepatitis D, an unmet medical need","author":"Caviglia","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib59","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S0618-8278(19)30058-1","article-title":"End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection","volume":"70","author":"Etzion","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100294_bib60","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib61","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02580-20","article-title":"Distinct cytokine profiles correlate with disease severity and outcome in longitudinal studies of acute hepatitis B virus and hepatitis D virus infection in chimpanzees","volume":"11","author":"Engle","year":"2020","journal-title":"mBio"},{"issue":"12","key":"10.1016\/j.jhepr.2021.100294_bib63","first-page":"895","article-title":"An animal study on transmission of hepatitis B virus through mosquitoes","volume":"108","author":"Zheng","year":"1995","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib64","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/jvi.68.2.1052-1058.1994","article-title":"Expression of the hepatitis delta virus large and small antigens in transgenic mice","volume":"68","author":"Guilhot","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.jhepr.2021.100294_bib65","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JVI.75.8.3600-3604.2001","article-title":"Deleterious effects of hepatitis delta virus replication on host cell proliferation","volume":"75","author":"Wang","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100294_bib66","first-page":"187","article-title":"Immunology of HDV infection","volume":"307","author":"Fiedler","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib67","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2009.10.036","article-title":"Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D","volume":"52","author":"Schaper","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2021.100294_bib69","article-title":"A\u00a0transient early HBV DNA increase during PEG-IFNalpha therapy of hepatitis D indicates loss of infected cells and is associated with HDV RNA and HBsAg reduction","author":"Anastasiou","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100294_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.10.006","article-title":"HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes","volume":"136","author":"Alfaiate","year":"2016","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib71","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2015.03.011","article-title":"Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection","volume":"63","author":"Giersch","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide","volume":"11","author":"He","year":"2015","journal-title":"Plos Pathog"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib73","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2017.05.010","article-title":"A\u00a0new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction","volume":"67","author":"Suarez-Amaran","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"42","key":"10.1016\/j.jhepr.2021.100294_bib75","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","article-title":"Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation","volume":"112","author":"Tropberger","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib76","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.xcrm.2020.100060","article-title":"Hepatitis delta virus acts as an immunogenic adjuvant in hepatitis B virus-infected hepatocytes","volume":"1","author":"Tham","year":"2020","journal-title":"Cell Rep Med"},{"issue":"8150","key":"10.1016\/j.jhepr.2021.100294_bib77","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(79)92561-3","article-title":"Incidence and significance of antibodies to delta antigen in hepatitis B virus infection","volume":"2","author":"Rizzetto","year":"1979","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000282076","article-title":"Hepatitis delta: immunopathogenesis and clinical challenges","volume":"28","author":"Grabowski","year":"2010","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jviromet.2011.11.001","article-title":"Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard","volume":"179","author":"Ferns","year":"2012","journal-title":"J\u00a0Virol Methods"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib80","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1128\/JCM.43.5.2363-2369.2005","article-title":"Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients","volume":"43","author":"Le Gal","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib81","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jgh.14617","article-title":"The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection","volume":"34","author":"Townsend","year":"2019","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jhepr.2021.100294_bib82","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gutjnl-2014-306767","article-title":"Effects of HDV infection and pegylated interferon alpha treatment on the natural killer cell compartment in chronically infected individuals","volume":"64","author":"Lunemann","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2019.04.009","article-title":"Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells","volume":"71","author":"Dias","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.gastro.2018.08.061","article-title":"Insights from antiviral therapy into immune responses to hepatitis B and C virus infection","volume":"156","author":"Rehermann","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jhepr.2021.100294_bib86","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1478-3231.2011.02593.x","article-title":"Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment","volume":"31","author":"Grabowski","year":"2011","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib87","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1128\/jvi.71.3.2241-2251.1997","article-title":"Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles","volume":"71","author":"Nisini","year":"1997","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib88","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/infdis\/jiy549","article-title":"Detection of a broad range of low-level major histocompatibility complex class II-restricted, hepatitis delta virus (HDV)-Specific T-cell responses regardless of clinical status","volume":"219","author":"Landahl","year":"2019","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2021.100294_bib89","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.035","article-title":"Hepatitis D virus-specific CD8(+) T cells have a memory-like phenotype associated with viral immune escape in patients with chronic hepatitis D virus infection","author":"Kefalakes","year":"2019","journal-title":"Gastroenterology"},{"issue":"Pt 10","key":"10.1016\/j.jhepr.2021.100294_bib90","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1099\/vir.0.80183-0","article-title":"Identification of novel HLA-A\u22170201-restricted CD8+ T-cell epitopes on hepatitis delta virus","volume":"85","author":"Huang","year":"2004","journal-title":"J\u00a0Gen Virol"},{"issue":"13","key":"10.1016\/j.jhepr.2021.100294_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01891-17","article-title":"Amino acid substitutions within HLA-B\u221727-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8(+) T cells","volume":"92","author":"Karimzadeh","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100294_bib92","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.02.003","article-title":"Mutations in hepatitis D virus allow it to escape detection by CD8+ T cells and evolve at the population level","author":"Karimzadeh","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhepr.2021.100294_bib93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/0074-02760160035","article-title":"Correlation between TH1 response standard cytokines as biomarkers in patients with the delta virus in the western Brazilian Amazon","volume":"111","author":"Nicolete","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jhepr.2021.100294_bib94","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib95","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.jhepr.2021.100294_bib96","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4 T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jhepr.2021.100294_bib97","article-title":"T-cell immunity against the hepatitis C virus: a persistent research priority in an era of highly effective therapy","author":"Smith","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhepr.2021.100294_bib98","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","article-title":"Cell-mediated immunity and the outcome of hepatitis C virus infection","volume":"58","author":"Shoukry","year":"2004","journal-title":"Annu Rev Microbiol"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib99","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","article-title":"Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes","volume":"175","author":"Schulze zur Wiesch","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI133222","article-title":"CD4+ T cell responses in human viral infection: lessons from hepatitis C","volume":"130","author":"Binder","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib101","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100294_bib102","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0032-1323631","article-title":"Perspectives for a vaccine against hepatitis delta virus","volume":"32","author":"Roggendorf","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2021.100294_bib104","doi-asserted-by":"crossref","first-page":"104898","DOI":"10.1016\/j.antiviral.2020.104898","article-title":"Animal models for the study of human hepatitis B and D virus infection: new insights and progress","volume":"182","author":"Burwitz","year":"2020","journal-title":"Antivir Res"},{"issue":"6285","key":"10.1016\/j.jhepr.2021.100294_bib105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/346629a0","article-title":"Viral escape by selection of cytotoxic T cell-resistant virus variants in\u00a0vivo","volume":"346","author":"Pircher","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib106","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00430-014-0372-z","article-title":"Mutational escape of CD8+ T cell epitopes: implications for prevention and therapy of persistent hepatitis virus infections","volume":"204","author":"Timm","year":"2015","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.jhepr.2021.100294_bib107","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1128\/JVI.02847-06","article-title":"Positive selection of hepatitis delta antigen in chronic hepatitis D patients","volume":"81","author":"Wang","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib108","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/JVI.01499-09","article-title":"Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution","volume":"84","author":"Kasprowicz","year":"2010","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.jhepr.2021.100294_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"Plos Pathog"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147812","article-title":"Pooled-peptide epitope mapping strategies are efficient and highly sensitive: an evaluation of methods for identifying human T cell epitope specificities in large-scale HIV vaccine efficacy trials","volume":"11","author":"Fiore-Gartland","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jhepr.2021.100294_bib111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.it.2005.11.001","article-title":"Have we cut ourselves too short in mapping CTL epitopes?","volume":"27","author":"Burrows","year":"2006","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.jhepr.2021.100294_bib112","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1084\/jem.179.5.1613","article-title":"Peptide size selection by the major histocompatibility complex-encoded peptide transporter","volume":"179","author":"Momburg","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.jhepr.2021.100294_bib113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-5793(94)00665-2","article-title":"Existence of a molecular ruler in proteasomes suggested by analysis of degradation products","volume":"349","author":"Wenzel","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhepr.2021.100294_bib114","first-page":"2680160","article-title":"Fundamentals and methods for T- and B-cell epitope prediction","volume":"2017","author":"Sanchez-Trincado","year":"2017","journal-title":"J\u00a0Immunol Res"},{"issue":"3","key":"10.1016\/j.jhepr.2021.100294_bib115","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood-2004-06-2336","article-title":"The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jhepr.2021.100294_bib116","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1128\/JVI.77.13.7330-7340.2003","article-title":"Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences","volume":"77","author":"Altfeld","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2021.100294_bib117","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Prim"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555921000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:46Z","timestamp":1762900006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555921000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2589555921000707"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100294","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human hepatitis D virus-specific T cell epitopes","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2021.100294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100294"}}